First Header Logo Second Header Logo

Connection

Thomas Lycan to Topotecan

Back to Details
This is a "connection" page, showing publications Thomas Lycan has written about Topotecan.
Thomas Lycan
Connection Strength
0.141
Topotecan
  1. Lycan TW, Pardee TS, Petty WJ, Bonomi M, Alistar A, Lamar ZS, Isom S, Chan MD, Miller AA, Ruiz J. A Phase II Clinical Trial of CPI-613 in Patients with Relapsed or Refractory Small Cell Lung Carcinoma. PLoS One. 2016; 11(10):e0164244.
    View in: PubMed
    Score: 0.141
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.